Skip to main content

Insights for possible association and impact of thyroidectomy to osteoarthritis

Abstract

Background and aim of study

Thyroidectomy and osteoarthritis have drawn more attention in last decades due to increase various local and systemic risk factors. This study is aimed to determine the association and impact between thyroidectomy and osteoarthritis by serological measurement of most specific related markers.

Results

Measurement of thyroid markers showed the level of thyroid-stimulating hormone (TSH) was significantly increased, while parathyroid hormone (PTH), triiodothyronine (T3), and thyroxine (T4) levels were decreased in osteoarthritis subjected to thyroidectomy group (OTG) when compared to hyperthyroidism subjected to thyroidectomy group (TG), osteoarthritis group (OG), and healthy control group (CG). Detection the activity of bone markers showed the level of R-factor was significantly elevated concomitant with significant reduction in Dickkopf related protein 1 (DKK1), human hyaluronan-binding protein 2 (HABP2), osteocalcin (OC) in OG and OTG groups, while osteopontin (OPN) and procollagen I C-terminal propeptide (PICP) were significantly increased and decreased in TG and OTG. Furthermore, the level of S100 Calcium binding protein (S100CBP) showed significant decreased in patient’s groups, while TG with OTG groups exhibited significant reduction in sclerostin (SOST) concentration. Regarding the inflammatory markers, the levels of interleukin-1 (IL-1) was increased in the OTG, while the level of interleukin-10 (IL-10) was increased in OG and TG groups, and reduced in OTG. While, the level of transforming growth factor-beta (TGF-β) was decreased in OG and TG associated with significant increases in tumor necrosis factor-alpha level (TNF-α) in OTG. Measurement of oxidant and antioxidant activity markers showed the levels of catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) were significantly reduced in all patient’s groups compared to control, except the level of CAT in TG, whereas, malondialdehyde (MDA) level was increased in OG and OTG patients. Furthermore, the levels of Alkaline phosphatase (ALP), C-Reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were increased in all patient groups compared to control, while fatty acid-binding protein (FABP) level was increased in OTG only.

Conclusion

This unique study in Iraq is identified the interaction effect and impact of thyroidectomy to osteoarthritis according to the results that showed various changes and degree of correlation of study biomarkers in all patient groups, however more depth of specific quantitative and qualitative studies are required to support this association and the impact claim at molecular level.

1 Background

Thyroid gland and its hormones have crucial roles in development of several organs associated with homeostatic controlling of fundamental physiological mechanisms related to energy expenditure and body growth [1]. In clinical practice, thyroid diseases are frequently observed as a result of functional abnormalities due to hyper and hypo production of thyroid hormones or through structural malformation development such as goiter, adenoma and carcinoma [2, 3]. Overactivity of thyroid gland (hyperthyroidism) can produce large quantities of thyroxine (T4) hormone which result in acceleration the rate of body metabolism, unintentional emaciation, and irregular tachycardia [4]. Hence, several therapies have been applied to manage the overproduction of thyroid hormones including beta-blockers, anti-thyroid medications, radioactive iodine, and surgery [5,6,7]. Thyroidectomy is a well-described surgical procedure used to excise the thyroid gland for treatment of hormonal and benign diseases that are not responsive to medical management as well as for malignancy [8]. Although, there is minimum occurrence of persistent complications post thyroidectomy, two possible complications might be raised as a result of close anatomic proximity of thyroid gland including recurrent laryngeal nerves and parathyroid glands. Furthermore, several multiple risk factors such as surgeon experience, surgical volume, thyroid pathology, procedure-related factors, and patient-related factors could involve in raising the occurrence of thyroidectomy possible complications [9,10,11]. However, careful operative technique and systemic strategy can prevent or decrease the incidence of complications [12, 13].

Osteoarthritis is a multifactorial most common joint disorder which defined clinically by presence of aching, pain and stiffness of the joint due to interaction of local and systemic risk factors [14]. Additional risk factors that relatively important might be varied based on the type of joints and stages of disease, as well as the development or progression of disease and the radiographic or systemic disease [14, 15]. Worldwide, no consistently effective methods are available to prevent development of osteoarthritis or control its progression, while the symptomatic therapies have provided few benefits for several patients [16].

In Iraq, several studies were carried solely in patients with thyroidectomy [17, 18] or osteoarthritis [19, 20]. However, there is no particular specific study identify the several serological markers changes and correlation between both diseases, therefore, this represents the unique Iraqi study which aimed to investigate the various serological markers alteration and the association and impact of thyroidectomy to osteoarthritis through measurement the concentration of various immunological, thyroid, bone, antioxidant and other serum markers using the serological assay, sandwich Enzyme Linked Immunosorbent Assay (ELISA).

2 Materials and methods

2.1 Ethical approval

This study was performed under a license of Scientific Committee in College of Medicine University of Wasit under license number (139 in 02/11/2021). All participant informed about this study, and verbal consent from all was obtained.

2.2 Exclusion criteria

The excluded criteria of this study were set which including the participant that suffer from malignancy, and other acute or chronic diseases including renal and liver condition. Furthermore, patients with immunodeficiency and other immune disorder were excluded from this study. Moreover, patients under certain medication like corticosteroid or hormonal therapy. Besides that, the females within the time of menstruation were further excluded from the study.

2.3 Study limitations

The considerable limitations of the current study are the limited number of participants in the study and the difficulties to obtained consent from some patients to involve in the study. Furthermore, due to very limited number of male patients, the study only involved female patients.

2.4 Study design and Samples

Totally, 120 women having an average age (40–65 years) and weight (60–90 kg) were categorized equally at four groups based on disease as the following:

  1. 1.

    TG: Hyperthyroidism patients subjected recently to thyroidectomy.

  2. 2.

    OG: Patients having a history of osteoarthritis.

  3. 3.

    OTG: Patients having a history of osteoarthritis and subjected recently to thyroidectomy.

  4. 4.

    CG: Healthy individuals having free acute or chronic diseases.

The thyroidectomy was conducted at The Red Crescent and Al-Karama Hospitals (Wasit, Iraq) from April (2019) to January (2022). After 12 h overnight fasting, the samples of blood were collected from the patients of TG and OTG in the hypothyroid phase as well as from the OG patients and CG individuals into free-anticoagulant and anticoagulant (sodium citrate) tubes. The serum samples were kept at 4ºC in the labeled Eppendorf tubes, and placed into darken boxes to avoid the phytochemical effects. Anticoagulant blood samples were applied directly for automated measurement of erythrocyte sedimentation rate (ESR).

2.5 Serology

Following the manufacturers’ instructions of ELISA kits (Sunlong Biotech, Zhejiang, China), thyroid (parathyroid hormone (PTH), thyroid stimulating hormone (TSH), triiodothyronine (T3) and thyroxine (T4)), bone (Dickkopf related protein 1 (DKK1), human hyaluronan-binding protein 2 (HABP2), osteocalcin (OC), osteopontin (OPN), procollagen I C-terminal propeptide (PICP), R-factor, S100 Calcium binding protein (S100CBP) and sclerostin (SOST)), immune (interleukin-1 (IL-1), interleukin-10 (IL-10), transforming growth factor-beta (TGF) and tumor necrosis factor-alpha (TNF-α)), antioxidant (catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD) and malondialdehyde (MDA)) and other (Alkaline phosphatase (ALP), C-Reactive protein (CRP), erythrocyte sedimentation rate (ESR) and fatty acid-binding protein (FABP)) markers were measured and the concentration of markers were calculated by plotting the concentrations of the Standard of each marker and its OD on x-axis and y-axis, respectively, and plotting the samples’ ODs on Y-axis.

2.6 Statistical analysis

The t-test and One-Way ANOVA in GraphPad Prism Software (GraphPad Software Inc., California, USA) were applied to analysis of obtained data at a significance of P < 0.05 (*), P < 0.01 (**), P < 0.001 (***) and P < 0.0001 (****) to identify the changes between the study groups based on measurement of serological markers. Furthermore, the correlation between markers within the groups were performed using Pearson correlation analysis in SPSS software v29 (IBM SPSS, Chicago, USA). The data displayed as Mean ± Standard Deviation of Mean (M ± SD).

3 Results

The obtaining data of thyroid markers were displayed a significant variation between and within the patient groups (OG, TG and OTG) when compared to CG (Fig. 1). The level of PTH is significantly decreased in OTG (37.48 ± 1.763 picograms per milliliter (pg/ml)) when compared to TG (46.9 ± 2.926 pg/ml), OG (64.62 ± 1.633 pg/ml) and CG (67.15 ± 1.734 pg/ml), whereas the TSH level is remarkably elevated in TG (2.461 ± 0.181 pg/ml) and OTG (3.087 ± 0.199 pg/ml) compare to OG (0.693 ± 0.0281 pg/ml) and CG (0.606 ± 0.0392 pg/ml). Furthermore, significant declined of T3 concentration was observed in OTG (35.139 ± 1.76 pg/ml) and TG (59.999 ± 0.68 pg/ml) when compared to CG (277.4 ± 27.47 pg/ml). Moreover, the level of T4 was significantly decreased in OG (37.7 ± 2.02 nanogram per milliliter (ng/ml)), TG (9.194 ± 0.498 ng/ml) and OTG (4.86 ± 0.515 ng/ml) when compared to CG (46.213 ± 2.12 ng/ml), whereas the relation between the markers and within the study groups showed statistical positive relationship between PTH and T3 in TG and between T3 and T4 in OTG. No further statistically significant positive or negative relations were seen (Table 1).

Fig. 1
figure 1

Serum concentration of thyroid markers. The level of PTH was significantly reduction in TG and OTG groups compared to control. The OG, TG, and OTG groups exhibited significant elevation of TSH compared to control group. The level of T3 was significantly decreased in TG and OTG compared to CG and OG, while the level of T4 was significantly decreased in all patient groups compared to control group

Table 1 Correlations between thyroid markers in study groups

The obtaining levels of bone specific markers from OG, TG and OTG were varied significantly (P < 0.0001) when compared to CG. The estimated concentrations of these markers in CG were DKK1 (81.605 ± 2.63 pg/ml), HABP2 (37.45 ± 1.12 ng/ml), OC (28.13 ± 2.0068 ng/ml), OPN (1.63 ± 0.047 ng/ml), PICP (37 ± 1.98 ng/ml), R-factor (26.2 ± 3.336 unit per liter (U/L)), S100CBP (408.4 ± 15.259 pg/ml) and SOST (1.25 ± 0.105 ng/ml) (Fig. 2). Significant decreases in the levels of DKK1 (31.394 ± 1.81 pg/ml), HABP2 (3.868 ± 0.1 ng/ml), OC (13.73 ± 0.934 ng/ml) and S100CBP (206.2 ± 25.41 pg/ml) were seen in OC, associated with significant increases in the level of R-factor (190.7 ± 17.85 U/L) and SOST (1.78 ± 0.176 ng/ml) compare to CG. Furthermore, the TG exhibited significant increase in the levels of OPN (2.78 ± 0.204 ng/ml) and SOST (2.82 ± 0.183 ng/ml), concomitant with significant reduction in the levels of HABP2 (34.522 ± 1.241 ng/ml), PICP (22.15 ± 1.52 ng/ml) and S100CBP (167 ± 6.673 pg/ml) compared to CG. Moreover, the recorded significant elevation in the levels of R-factor (271.3 ± 23.98 U/L), OPN (3.17 ± 0.218 ng/ml) and SOST (3.63 ± 0.134 ng/ml) were seen in the OTG, while the levels of DKK1 (28.625 ± 1.388 pg/ml), HABP2 (3.016 ± 0.117 ng/ml), OC (12.81 ± 0.76 ng/ml), PICP (17.57 ± 1 ng/ml), and S100CBP (169.1 ± 3.796 pg/ml) were significantly declined compare to CG.

Fig. 2
figure 2

Serum concentration of bone markers. The concentration of DKK1, HABP2, and OC were significantly decreased in OG and OTG compared to control group. The OG, TG, and OTG groups exhibited significant elevation of SOST level, while OPN level was increased only in the TG and OTG compared to control. However, the levels of S100CBP was reduced significantly in all diseased groups, while only TG and OTG displayed significant reduction in the level of PICP compared to control. Whereas, the level of R-factor was increased in both OG and OTG groups compared to control

Whereas, the correlation between bone markers and within the study groups showed statistical negative correlation between HABP2 and PICP in OG (Table 2). Further significant negative relationship between DKKI and SOST, and S100CBP with OPN in OTG were seen (Table 2). In CG there was positive relationship between OC and SOST marker at significant level (Table 2). All remaining bone markers within the study groups felt to show further significant positive or negative relationship.

Table 2 Correlations between several bone markers in study groups

In relation to immune markers (Fig. 3), the concentration of IL-1 was increased significantly in the OTG (272.91 ± 16.33 pg/m) only compared to the CG. Furthermore, the level of IL-10 was also significantly elevated in the OG (63.86 ± 3.02 pg/ml) and the TG (60.55 ± 3.324 pg/ml), while significant decrease was recorded in the OTG (20.22 ± 2.157 pg/ml) compare to the CG. The TGF-β level was significantly declined in the OG (75.16 ± 2.854 pg/ml) and the TG (102.29 ± 3.918 pg/ml) when compared with CG. Moreover, the level of TNF-α was significant reduction in both OG (148.78 ± 6.263 pg/ml) and TG (152.23 ± 6.023 pg/ml), while increased in the OTG (289.52 ± 11.782 pg/ml) compare to CG. Whereas, the correlation between these markers and within the study groups showed neither significant positive relationship nor negative relationship as seen in (Table 3).

Fig. 3
figure 3

Serum concentration of immune markers. The OTG group exhibited significant increase in level of IL-1 compared to control, while the level of IL-10 was decreased in OTG and increased in OG and TG groups compared to control. Both OG and TG groups showed significant reduction in the level of TGF-β and TNF-α compared to control, while OTG exhibited significant elevation in the level of TNF-α compared to control

Table 3 Correlations between immunological markers in study groups

Concerning the oxidant and antioxidant activity (Fig. 4), the levels of CAT were decreased significantly in the OG (20.02 ± 0.94 pg/ml) and the OTG (17.26 ± 1.346 pg/ml) compared to recorded level in the CG (36.61 ± 3.083 pg/ml). Similarly, the levels of both GPx and SOD were significant reduction in the OG (400.16 ± 20.056 pg/ml and 18.22 ± 1.605 U/ml, respectively), the TG (543.81 ± 22.925 pg/ml and 19.69 ± 1.07 U/ml, respectively) and OTG (491 ± 29.434 pg/ml and 13.57 ± 0.76 U/ml, respectively) in comparison with the obtained levels in the CG (646.77 ± 30.813 pg/ml and 24.56 ± 1.422 U/ml, respectively). Whereas, the result displayed significant elevation in the level of MDA in the OG (127.48 ± 9.253 ng/ml) and the OTG (182.77 ± 10.474 ng/ml) when compared to the estimation level in the CG (84.59 ± 2.283 ng/ml). On the other hand, the correlation between the markers within the study groups showed significant negative relationship between CAT and MDA in OG, and also between MDA and SOD in OTG (Table 4). The remaining markers in various study groups felt to appear significant relationship.

Fig. 4
figure 4

Serum concentration of antioxidant markers. All diseased groups showed significant reduction in the level of GPx and SOD, while CAT level was decreased in OG and OTG compared to control group, while the level of MDA was increased significantly in OG and OTG groups compared to control

Table 4 Correlations between antioxidant markers in study groups

Regarding other study markers (Fig. 5), the concentrations of the ALP were elevated significantly in the OG (6.67 ± 0.556 ng/ml), the TG (7.13 ± 0.313 ng/ml) and the OTG (7.26 ± 0.363 ng/ml) compared to the CG (4.26 ± 0.093 ng/ml). Similarly, the levels of CRP were significantly elevated in the OG (23.93 ± 4.506 pg/ml), the TG (42.9 ± 5.661 pg/ml) and the OTG (112.41 ± 14.175 pg/ml) when compared to the CG (5.48 ± 1.023 pg/ml). Furthermore, significant increases in the levels of ESR were seen in the OG (35.9 ± 5.673 mm per hour (mm/h)), the TG (22.9 ± 3.114 mm/h) and the OTG (41.9 ± 4.523 mm/h) in comparison with the estimated level in the CG (14.4 ± 1.771 mm/h). Moreover, only OTG exhibited significant elevation of FABP concentration (16.57 ± 0.851 pg/ml) when compared to CG (13.7 ± 0.721 pg/ml). Whereas, the correlation between these markers and within the study groups showed neither significant positive relation nor significant negative relation (Table 5).

Fig. 5
figure 5

Serum concentration of other markers. The concentration of ALP, CRP, and ESR were significantly increased in all diseased groups compared to control, whereas only OTG group exhibited significant elevation in the level of FABP compared to control group

Table 5 Correlations between some factors in study population

4 Discussion

Thyroid hormones have demonstrated to play crucial several biological activities in the regulation of bone homeostasis, skeletal growth and metabolism [21]. The current study results manifested significant impact of thyroidectomy on thyroid hormones (PTH, T3 and T4) in osteoarthritic patients, and this might be attributed to the widely expression of thyroid hormones in bone, since the bone development and turnover are largely controlled by thyroid hormone. In pre-thyroidectomy patients, hyperthyroidism can accelerate the bone turnover, and bone mineral density losting; whereas, hypothyroidism in post thyroidectomy patients can reduce the processes of bone formation and increase the retardation of bone growth in childhood in addition to mild muscle weakness, generalized body ache and myalgia, adhesive capsulitis, carpal and tarsal tunnel syndrome, trigger finger, limited joint mobility, tendinitis, myopathy, muscle cramps, stiffness, and synovitis in the adults [22]. As obtained in this study, other researchers have been confirmed that alteration of TSH possesses strong impact to develop osteoarthritis with suggestion that increases of TSH levels might be attributed to the role of other variables such as homocysteine, insulin sensitivity indices and lipoprotein [18, 23]. In a recent experimental study, the authors have demonstrated that the role of analgesics in exhibiting various effects on thyroid functions, and these effects are depended on both the drug itself and its doses [24].

Importantly, the OTG patients in the current study are significantly exhibited high levels of R-factor, OPN and SOST associated with low levels of DKK1, HABPS, OC, PICP and S100CBP markers. The R-factor might increase due to impact of thyroidectomy on autoimmune features, immunoglobulin aggregation, or idiopathic antibody interaction [25]. The OPN is a multifunctional extracellular structural protein and therefore an organic component of bone. High levels of OPN in TG and OTG might a reflex to hyperthyroidism in pre-thyroidectomy patients, and the level of OPN could have negative effect on mineral density of bone and positive effect on bone turnover [26]. Furthermore, increasing the levels of SOST in the TG and OTG might be due to hyperthyroidism in pre-thyroidectomy patients which results in excess thyroid and parathyroid hormones, alterations in TSH concentrations, estrogen deficiency and mechanical unloading [27]. Nuclear DKK1 protein, an inhibitor of Wnt signaling which produced in excess in the inflamed rheumatoid joints by immune cells. It is expressed locally at high concentration in osteoblasts and osteocytes which prevent the reduction of bone formation and mass and regulate several related-genes involved in the detoxification of chemotherapeutic agents in addition to blocking the differentiation of sufficient osteoblasts to prevent bone loss [28]. The low level of DKK1 seen in OTG patients might coincidental with the results reported by Kim et al. [29]. The functional and pathogenic role of DKK1 signaling pathway was investigated by administration of DKK1 as a therapeutic agent that contributes in inhibition of thyroid cancer with consequent inhibition of cell migration and invasion [30]. Recent several studies confirmed that the HABPS is a human protein encoded by HABP2 gene which play critical role in development of thyroid cancer [31,32,33]. OC is a small non-collagenous protein hormone, which first identified as a calcium-binding protein and found in bone and dentin. Significant decreased of OC levels were seen in OG and OTG patients but not in TG, considering this change is not definitive or irrelevant. The high level of OC in hyperthyroid patients, and normal or subnormal concentration in hypothyroid patients suggesting that this change might control decreases in bone turnover [34]. In the other study, the clear reduction of OC as well as PICP in a patient due to therapeutic oral intake of bisphosphonates inhibits the bone turnover [35]. Thus, the study suggested that decreasing in a heterotrimeric glycoprotein PICP might correlate with the hypothyroidism as result of thyroidectomy. Obviously, S100CBP is new protein plays a role in angiogenesis, extracellular matrix remodeling, tumor microenvironment, and potentially aid in discrimination of follicular and papillary thyroid tumors as it over-expressed in metastatic papillary carcinomas [36]. Therefore, low level of S100CBP in the current study groups could be due to either benign hyperthyroidism which is the most form of disease, or to success of surgeon in removing of multifocal lesions during thyroidectomy. Although, several studies revealed S100CBP as a novel candidate biomarker, diagnostic and functional significance that requires further investigation.

The study identified that there were significant variations in levels of immune markers (IL-1, IL-10, INF-α and TGF-β) of patient’s study groups when compared to healthy CG. Various authors recorded the plausible relation of immunity with the prognosis of thyroidectomy; however, the results are inconsistent due to the influence of other factors such as the phase of inflammation, type of thyroid dysfunction or tumor, type of surgery (laparoscopic or conventional) and patient’s age that has a great prognostic value of individual immunological markers [37]. Patients undergoing surgery or trauma are often suffered from acquired immunologic deficits that may predispose them to sepsis, in addition to excessive production of cytokines such as IL and TNF [38]. Miccoli et al. [39] concluded that TGF-β serum levels seem to be correlated with pain evaluation, demonstrating that decreased postoperative distress is an objective outcome.

Antioxidants are molecules that fight oxidation, a chemical reaction that can produce high free radicals and chain reactions causing damage to the cells. The study findings showed a significant reduction in the levels of CAT, GPx and SOD, concomitant with elevation of MDA. In patients suffer from arthritis, Sarban et al. [40] reported an increasing of lipid peroxidation and decreasing of plasma total antioxidant capacity due to inflammatory reaction. Grover and Samson [41] showed that the antioxidant supplementation is benefit for pain relief and function of knee arthritis. On other hand, many authors detected imbalance between antioxidative system and free radicals production in individuals of thyroid dysfunction confirming that the oxidative stress was elevated due to thyroidectomy and thyroarathyroectomy in spite of using the replacement drugs [42]. Pasko [43] determined that there was deep imbalance in oxide modification of proteins-antioxidant defense system in patients having the signs of hypothyroidism, which indicate the great effect of oxidative stress in pathogenesis of post-operative hypoparathyroidism suggesting that the using of antioxidant-antihypoxant drugs in early postoperative period provide an area of complex therapy for patients with signs of post-operative hypoparathyroidism.

Significant elevation of ALP, CRP and ESR in patients of all study groups, and increasing of FABP in patients of OTG were observed in the current study. The increasing level of serum ALP agrees with the findings of Bin-Hong et al. [44], and conflicted with Al-Janabi et al. [18]. This finding might be explained by increasing bone turnover and decreasing the bone quality in patients of OG and OTG, and/or thyroidectomy induced hepatic toxicity in TG and OTG. Jin et al. [45] showed that the higher level of serum CRP in osteoarthritis was significantly associated with the grade of systemic inflammation as well as with the pain score and physical function. Post thyroidectomy, Jian et al. [46] revealed a positive association to increasing levels of serum CRP and draining volume on first postoperative day, draining tube removal time, dysphagia, pain and cosmetic satisfaction. Although, the study detected strong significant changes of CRP and ESR levels among patients of study groups with no significant positive or negative correlation. Other studies were concluded a modest correlation between each other, and a weakly correlation with disease activity [47, 48]. As obtained in this study, the poor action of FABP as promising biomarkers of burden of disease in osteoarthritis was showed by other [49]; however, higher levels in patients with overt hypothyroidism was seen in OTG similar to that seen in other study [50]. The increased FABP levels may refer to a pre-diabetic phase, subclinical atherosclerosis, and disruption in fatty acid metabolism [50].

5 Conclusion

Routine determination of the various serobiochemical markers levels prior and post-thyroidectomy makes it possible to assess the severity of illness in osteoarthritic patients. Rapid increasing in incidence of osteoarthritis suggests that the crucial impact of thyroidectomy on health care and public health systems in future, with providing compelling evidence for the markers that significantly altered between thyroidectomy and osteoarthritis. Long-term and precise specific studies with involvement of a large number of patients including male and female appeared necessary in providing more reliable and valuable data.

Availability of data and materials

All obtained and analyzed data in this study are including in this manuscript.

Abbreviations

TSH:

Thyroid-stimulating hormone

PTH:

Parathyroid hormone

T3:

Triiodothyronine

T4:

Thyroxine

OTG:

Osteoarthritis subjected to thyroidectomy group

TG:

Hyperthyroidism subjected to thyroidectomy group

OG:

Osteoarthritis group

CG:

Healthy control group

DKK1:

Dickkopf related protein 1

HABP2:

Human hyaluronan-binding protein 2

OC:

Osteocalcin

OPN:

Osteopontin

PICP:

Procollagen I C-terminal propeptide

S100CBP:

S100 Calcium binding protein

SOST:

Sclerostin

IL-1:

Interleukin-1

IL-10:

Interleukin-10

TGF-β:

Transforming growth factor-beta

TNF-α:

Tumor necrosis factor-alpha

CAT:

Catalase

SOD:

Superoxide dismutase

GPx:

Glutathione peroxidase

MDA:

Malondialdehyde

ALP:

Alkaline phosphatase

CRP:

C-Reactive protein

ESR:

Erythrocyte sedimentation rate

FABP:

Fatty acid-binding protein

OD:

Optical density

ANOVA:

Analysis of variance

ng/ml:

Nanogram per milliliter

pg/ml:

Picogram per milliliter

U/L:

Unit per liter

mm/h:

Milliliter per hour

References

  1. Nilsson M, Fagman H (2017) Development of the thyroid gland. Development 144(12):2123–2140. https://doi.org/10.1242/dev.145615

    Article  CAS  PubMed  Google Scholar 

  2. Schlumberger M, Leboulleux S, Catargi B et al (2018) Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. Lancet Diabetes Endocrinol 6(8):618–626. https://doi.org/10.1016/S2213-8587(18)30113-X

    Article  PubMed  Google Scholar 

  3. Williams GR, Bassett JD (2018) Thyroid diseases and bone health. J Endocrinol Invest 41(1):99–109. https://doi.org/10.1007/s40618-017-0753-4

    Article  CAS  PubMed  Google Scholar 

  4. Guerri G, Bressan S, Sartori M et al (2019) Hypothyroidism and hyperthyroidism. Acta Biomed 90(Suppl 10):83–86. https://doi.org/10.23750/abm.v90i10-S.8765

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kitahara CM, De Gonzalez AB, Bouville A et al (2019) Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism. JAMA Intern Med 179(8):1034–1042. https://doi.org/10.1001/jamainternmed.2019.0981

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ross D, Cooper DS, Mulder JE (2017) Beta blockers in the treatment of hyperthyroidism. In Cooper D (ed) UpToDate, Waltham, MA

  7. Kravets I (2016) Hyperthyroidism: diagnosis and treatment. Am F Physic 93(5):363–370

    Google Scholar 

  8. Vassiliou I, Tympa A, Arkadopoulos N et al (2013) Total thyroidectomy as the single surgical option for benign and malignant thyroid disease: a surgical challenge. Arch Med Sci 9(1):74–78. https://doi.org/10.5114/aoms.2013.33065

    Article  PubMed  PubMed Central  Google Scholar 

  9. Duclos A, Peix JL, Colin C et al (2012) Influence of experience on performance of individual surgeons in thyroid surgery: prospective cross sectional multicentre study. BMJ. https://doi.org/10.1136/bmj.d8041

    Article  PubMed  PubMed Central  Google Scholar 

  10. Christou N, Mathonnet M (2013) Complications after total thyroidectomy. J Visc Surg 150(4):249–256. https://doi.org/10.1016/j.jviscsurg.2013.04.003

    Article  CAS  PubMed  Google Scholar 

  11. Hauch A, Al-Qurayshi Z, Randolph G, Kandil E (2014) Total thyroidectomy is associated with increased risk of complications for low-and high-volume surgeons. Ann Surg Oncol 21(12):3844–3852. https://doi.org/10.1245/s10434-014-3846-8

    Article  PubMed  Google Scholar 

  12. Berri T, Houari R (2013) Complications of thyroidectomy for large goiter. Pan Afr Med J 16(138):1–5. https://doi.org/10.11604/pamj.2013.16.138.3277

    Article  Google Scholar 

  13. Périé S, Aït-Mansour A, Devos M et al (2013) Value of recurrent laryngeal nerve monitoring in the operative strategy during total thyroidectomy and parathyroidectomy. Eur Ann Otorhinolaryngol Head Neck Dis 130(3):131–136. https://doi.org/10.1016/j.anorl.2012.09.007

    Article  PubMed  Google Scholar 

  14. Zhang Y, Jordan JM (2010) Epidemiology of osteoarthritis. Clin Geriatr Med 26(3):355–369. https://doi.org/10.1016/j.cger.2010.03.001

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bastick AN, Belo JN, Runhaar J, Bierma-Zeinstra S (2015) What are the prognostic factors for radiographic progression of knee osteoarthritis? A meta-analysis. Clin Orthop Relat Res 473(9):2969–2989. https://doi.org/10.1007/s11999-015-4349-z

    Article  PubMed  PubMed Central  Google Scholar 

  16. Roos EM, Arden NK (2016) Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 12(2):92–101. https://doi.org/10.1038/nrrheum.2015.135

    Article  CAS  PubMed  Google Scholar 

  17. Qasim RH, Saeed HK, Al-Abbasi AM, Mohammed MM (2020) Hypocalcemia following thyroidectomy; a prospective study in Basrah. Iraq Bas J Surg 26(1):46–50. https://doi.org/10.33762/bsurg.2020.165483

    Article  Google Scholar 

  18. Al-Janabi G, Hassan HN, Al-Fahham A (2022) Biochemical changes in patients during hypothyroid phase after thyroidectomy. J Med Life 15(1):104–108. https://doi.org/10.25122/jml-2021-0297

    Article  PubMed  PubMed Central  Google Scholar 

  19. Amin A, Merza R, Baban MJ et al (2019) Symptomatic knee osteoarthritis and dyslipidaemia. A study from Kurdistan of Iraq. World F Med. 17(9):30–35. https://doi.org/10.7861/clinmed.20-2-s8

    Article  Google Scholar 

  20. Aziz KT, Rostam RA, Qasem AO (2021) Visfatin and correlated clinical parameters in Type 2 diabetes mellitus as diagnostic factor in osteoarthritis patients in Sulaimani, Iraq. Indian J Forensic Med Toxicol 15(4):1537–1542. https://doi.org/10.37506/ijfmt.v15i4.16926

    Article  CAS  Google Scholar 

  21. Li L, Li M, Pang Y et al (2019) Abnormal thyroid hormone receptor signaling in osteoarthritic osteoblasts regulates microangiogenesis in subchondral bone. Life Sci 239:116975. https://doi.org/10.1016/j.lfs.2019.116975

    Article  CAS  PubMed  Google Scholar 

  22. Kole AK, Roy R, Kole DC (2013) Rheumatic manifestations in primary hypothyroidism. Indian J Rheumatol 8(1):8–13. https://doi.org/10.1016/J.INJR.2012.12.005

    Article  Google Scholar 

  23. Hossain FM, Hong Y, Jin Y, Choi J, Hong Y (2019) Physiological and pathological role of circadian hormones in osteoarthritis: dose-dependent or time-dependent? J Clin Med 8(9):1415–1432. https://doi.org/10.3390/jcm8091415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nosivets D, Opryshko V, Shevchenko T (2022) Effect of non-steroidal anti-inflammatory drugs and paracetamol on the functional state of the thyroid gland in experimental osteoarthritis with hypothyroidism. Problems Endocr Pathol 79(1):93–99. https://doi.org/10.21856/j-pep.2022.1.13

    Article  Google Scholar 

  25. Lupoli GA, Barba L, Liotti A et al (2019) Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report. Medicine 98(5):1–3. https://doi.org/10.1097/MD.0000000000014178

    Article  Google Scholar 

  26. El-Zawawy HT, El-Aghoury AA, Azzam EZ, Deghady AAM, Abdellatif MA (2020) Osteopontin as a marker in thyroid disease: relation to body mass index. Endocr Metab Sci 1(1–2):100049. https://doi.org/10.1016/j.endmts.2020.100049

    Article  Google Scholar 

  27. Zygmunt A, Krawczyk-Rusiecka K, Skowrońska-Jóźwiak E et al (2021) The effect of recombinant human TSH on sclerostin and other selected bone markers in patients after total thyroidectomy for differentiated thyroid cancer. J Clin Med 10(21):4905–4918. https://doi.org/10.3390/jcm10214905

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Appel H, Janssen L, Listing J et al (2008) Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment. Arthritis Res Ther 10(5):1–8. https://doi.org/10.1186/ar2537

    Article  CAS  Google Scholar 

  29. Kim SM, Ryu V, Miyashita S et al (2021) TSH, hyperthyroidism, and bone mass. J Clin Endocrinol Metab 106(12):e4809–e4821. https://doi.org/10.1210/clinem/dgab548

    Article  PubMed  PubMed Central  Google Scholar 

  30. 이은정: Pathogenetic role of Wnt signaling pathway and the function of Dickkopf-1 in thyroid cancers (Doctoral dissertation, 서울대학교 대학원). 2013. https://hdl.handle.net/10371/121897.

  31. Zhang T, Xing M (2016) HABP2 G534E mutation in familial nonmedullary thyroid cancer. J Nat Cancer Inst 108(6):1–3. https://doi.org/10.1093/jnci/djv415

    Article  CAS  Google Scholar 

  32. HABP2 hyaluronan binding protein 2 [Homo sapiens (human)]. https://www.ncbi.nlm.nih.gov/gene/3026. 24-Apr-2022. https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Term=3026.

  33. Parad MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S (2021) Thyroid cancer and its associated factors: a population-based case-control study. Int J Cancer 149(3):514–521. https://doi.org/10.1002/ijc.33537

    Article  CAS  PubMed  Google Scholar 

  34. Martinez ME, Herranz L, De Pedro C, Pallardo LF (1986) Osteocalcin levels in patients with hyper-and hypothyroidism. Hormone Metab Res 18(03):212–214. https://doi.org/10.1055/s-2007-1012275

    Article  CAS  Google Scholar 

  35. Promberger R, Ott J, Kober F et al (2011) Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy. Thyroid 21(2):145–150. https://doi.org/10.1089/thy.2010.0067

    Article  CAS  PubMed  Google Scholar 

  36. Nucera C, Pontecorvi A (2012) Clinical outcome, role of BRAFV600E, and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer? Fron Endocrinol 3(1):1–8. https://doi.org/10.3389/fendo.2012.00033

    Article  CAS  Google Scholar 

  37. Lee KH, Seok EY, Kim EY et al (2019) Different prognostic values of individual hematologic parameters in papillary thyroid cancer due to age-related changes in immunity. Ann Surg Treat Res 96(2):70–77. https://doi.org/10.4174/astr.2019.96.2.70

    Article  CAS  PubMed  Google Scholar 

  38. Zheng C, Liu S, Geng P et al (2015) Minimally invasive video-assisted versus conventional open thyroidectomy on immune response: a meta analysis. Int J Clin Exp Med 8(2):2593–2599

    PubMed  PubMed Central  Google Scholar 

  39. Miccoli P, Rago R, Massi M et al (2010) Standard versus video-assisted thyroidectomy: objective postoperative pain evaluation. Surg Endosc 24(10):2415–2417. https://doi.org/10.1007/s00464-010-0964-7

    Article  PubMed  Google Scholar 

  40. Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38(11):981–986. https://doi.org/10.1016/j.clinbiochem.2005.08.003

    Article  CAS  PubMed  Google Scholar 

  41. Grover AK, Samson SE (2015) Benefits of antioxidant supplements for knee osteoarthritis: rationale and reality. Nutr J 15(1):1–13. https://doi.org/10.1186/s12937-015-0115-z

    Article  CAS  Google Scholar 

  42. Kaçmaz M, Atmaca M, Arslan A, Demir H, Özbay MF (2015) Oxidative stress in patients with thyroidectomy and thyroparathyroidectomy under replacement therapy. Endocrine 48(1):227–232. https://doi.org/10.1007/s12020-014-0270-6

    Article  CAS  PubMed  Google Scholar 

  43. Pasko AY (2019) The influence of the level of products of oxidal modification of proteins and enzymes of antioxidant protection on the process of post-operation hypoparathyroidism. Acta Med Leopol 25(4):11–17. https://doi.org/10.25040/aml2019.04.011

    Article  Google Scholar 

  44. Bin-Hong D, Fu-Man D, Yu L, Xu-Ping W, Bing-Feng B (2020) Effects of levothyroxine therapy on bone mineral density and bone turnover markers in premenopausal women with thyroid cancer after thyroidectomy. Endokrynol Pol 71(1):15–20. https://doi.org/10.5603/EP.a2019.0049

    Article  PubMed  Google Scholar 

  45. Jin X, Beguerie JR, Zhang W et al (2015) Circulating C reactive protein in osteoarthritis: a systematic review and meta-analysis. Ann Rheumat Dis 74(4):703–710. https://doi.org/10.1136/annrheumdis-2013-204494

    Article  CAS  PubMed  Google Scholar 

  46. Jian CX, Wu LM, Zheng ZF et al (2020) How should surgical approach in thyroidectomy be selected? A prospective study comparing the trauma of 3 different thyroidectomy surgical approaches. Surg Laparosc Endosc Percutan Tech 30(1):22–25. https://doi.org/10.1097/SLE.0000000000000743

    Article  PubMed  PubMed Central  Google Scholar 

  47. Keenan RT, Swearingen CJ, Yazici Y (2008) Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Clin Exp Rheumatol 26(5):814–819

    CAS  PubMed  Google Scholar 

  48. Peng CCH, Munir KM, Song L, Papadimitriou JC, Pennant MA (2020) Recurrent painful Hashimoto thyroiditis successfully treated by thyroidectomy. AACE Clin Case Rep 6(1):e9–e13. https://doi.org/10.4158/ACCR-2019-0184

    Article  PubMed  PubMed Central  Google Scholar 

  49. Schadler P, Lohberger B, Thauerer B, et al (2021) Fatty acid–binding protein 4 (FABP4) is associated with cartilage thickness in end-stage knee osteoarthritis. Cartilage 13 (2-Suppl): 1165S-1173S. https://doi.org/10.1177/19476035211011520.

  50. Gönülalan G, Kulaksizoğlu M, Taşyürek E, Gönen MS (2021) The relationship with serum heart type fatty acid binding protein and subclinical atherosclerosis in patients with hypothyroidism. Turkish J Diabet Obes 5(3):333–339. https://doi.org/10.1177/19476035211011520

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Authors gratefully acknowledge the cooperation of all study participants as well as the technical support of all hospitals and laboratories in Wasit province (Iraq).

Funding

No external funds were received (private funds only).

Author information

Authors and Affiliations

Authors

Contributions

NKA: Surgeon responsible of thyroidectomy and clinical examination of patients; AUA, SJJA, and HAJG: Collection and testing of samples. All authors were contributed in statistical analysis of the results with reading and approving of the final copy of the manuscript.

Corresponding author

Correspondence to Sattar J. J. AL-Shaeli.

Ethics declarations

Ethics approval and consent to participate

This study was performed under a license of Scientific Committees in College of Medicine University of Wasit (139 in 02/11/2021). All participants informed about this study, and verbal consent from all was obtained.

Consent for publication

Not applicable.

Competing interests

The authors declare that there are no competing interests or any personal or organization relation that affect this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Almaliky, N.K., Al-Sari, U.A., AL-Shaeli, S.J.J. et al. Insights for possible association and impact of thyroidectomy to osteoarthritis. Beni-Suef Univ J Basic Appl Sci 13, 99 (2024). https://doi.org/10.1186/s43088-024-00554-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43088-024-00554-1

Keywords